Tarsus Pharmaceuticals (TARS) - P/B ratio
P/B ratio as of December 2024 : 8.49
According to Tarsus Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 15.5478.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
P/B ratio by year
Year |
P/B ratio |
Change |
2024-12-31 | 8.63 | 153.48% |
2023-12-31 | 3.40 | 67.89% |
2022-12-31 | 2.03 | -27.36% |
2021-12-31 | 2.79 | -44.85% |
2020-12-31 | 5.06 | |
2019-12-31 | N/A | |
P/B ratio for similar companies or competitors
Company | P/B ratio | P/B ratio differencediff. | Country |
| 2.06 | -75.69% | ๐บ๐ธ USA |